http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130052731-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-24069
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
filingDate 2011-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e56672bb9941c3929e771662f2e0fc4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6431d1eb751bfe7983451a8763bf2b97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2df45eb3939410e27d8f9377f2de37b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e47434594fac08811ec8d554d0f81cd
publicationDate 2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20130052731-A
titleOfInvention Botulinum toxin dosing regimen for chronic migraine prevention
abstract Diseases such as headaches can be treated by administration of botulinum toxin to a patient suffering from such a disease, for example migraine headaches. Conjoined fixed location / fixed doses and options follow the pain variable dose, and an injection location paradigm is disclosed to optimize the clinical effectiveness of botulinum toxin administration in patients with chronic migraine headaches. The injection schedule is a fixed-position, fixed-dose injection regimen within 31-39 locations throughout the seven head / neck muscles, namely, the frontal muscles, the pectoral muscles, the nasal muscles, the larynx, the temporal muscles, the mitral muscles and the cervical spinal lateral muscles. Requires a minimum dose of 155 U.
priorityDate 2010-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553275
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID8312
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID8312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5905
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3121

Total number of triples: 38.